Chao-Hui Yu1, Cheng-Fu Xu, Hua Ye, Lan Li, You-Ming Li. 1. Department of Gastroenterology, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou 310003, Zhejiang Province, China.
Abstract
AIM: To investigate the early mortality of placebo-treated alcoholic hepatitis patients. METHODS: Mortality data about alcoholic hepatitis patients who participated in randomized placebo-controlled trials were searched from PubMed, EMBASE, and Cochrane Library, extracted and analyzed. RESULTS: A total of 661 placebo-treated patients in 19 trials were included. The overall mortality rate was 34.19% with a median observation time of 160 d (range 21-720 d). Hepatic failure, gastrointestinal bleeding and infection were the three main causes of death, accounting for 55.47%, 21.17% and 7.30% of all deaths, respectively. One-month mortality data about 324 placebo-treated alcoholic hepatitis patients in 10 trials were reported with a pooled mortality rate of 20.37%. The one-month mortality rate of patients with moderate to severe alcoholic hepatitis tended to be higher than that of general patients (22.69% vs 10.93%, P < 0.05), whereas no significant difference was observed between the patients from North America or Europe (22.43% vs 18.45%, P > 0.05), neither any difference was found between the studies published before and after 1990 (18.18% vs 21.88%, P > 0.05). CONCLUSION: Alcoholic hepatitis is a severe liver disease with a high mortality rate, and hepatic failure, gastrointestinal bleeding and infection are the three main causes of death.
AIM: To investigate the early mortality of placebo-treated alcoholic hepatitispatients. METHODS: Mortality data about alcoholic hepatitispatients who participated in randomized placebo-controlled trials were searched from PubMed, EMBASE, and Cochrane Library, extracted and analyzed. RESULTS: A total of 661 placebo-treated patients in 19 trials were included. The overall mortality rate was 34.19% with a median observation time of 160 d (range 21-720 d). Hepatic failure, gastrointestinal bleeding and infection were the three main causes of death, accounting for 55.47%, 21.17% and 7.30% of all deaths, respectively. One-month mortality data about 324 placebo-treated alcoholic hepatitispatients in 10 trials were reported with a pooled mortality rate of 20.37%. The one-month mortality rate of patients with moderate to severe alcoholic hepatitis tended to be higher than that of general patients (22.69% vs 10.93%, P < 0.05), whereas no significant difference was observed between the patients from North America or Europe (22.43% vs 18.45%, P > 0.05), neither any difference was found between the studies published before and after 1990 (18.18% vs 21.88%, P > 0.05). CONCLUSION:Alcoholic hepatitis is a severe liver disease with a high mortality rate, and hepatic failure, gastrointestinal bleeding and infection are the three main causes of death.
Authors: A Rambaldi; H H Saconato; E Christensen; K Thorlund; J Wetterslev; C Gluud Journal: Aliment Pharmacol Ther Date: 2008-03-20 Impact factor: 8.171
Authors: Nicholas C Boetticher; Craig J Peine; Paul Kwo; Gary A Abrams; Tushar Patel; Bashar Aqel; Lisa Boardman; Gregory J Gores; William S Harmsen; Craig J McClain; Patrick S Kamath; Vijay H Shah Journal: Gastroenterology Date: 2008-09-13 Impact factor: 22.682
Authors: Stephen Stewart; Martin Prince; Margaret Bassendine; Mark Hudson; Oliver James; David Jones; Chris Record; Christopher P Day Journal: J Hepatol Date: 2007-05-04 Impact factor: 25.083
Authors: Ashwani K Singal; Sudha Kodali; Lee A Vucovich; Victor Darley-Usmar; Thomas D Schiano Journal: Alcohol Clin Exp Res Date: 2016-06-02 Impact factor: 3.455
Authors: Jeongeun Hyun; Zhaoli Sun; Ali Reza Ahmadi; Sushant Bangru; Ullas V Chembazhi; Kuo Du; Tianyi Chen; Hidekazu Tsukamoto; Ivan Rusyn; Auinash Kalsotra; Anna Mae Diehl Journal: J Clin Invest Date: 2020-04-01 Impact factor: 14.808
Authors: Naaventhan Palaniyappan; Venkataraman Subramanian; Vidyasagar Ramappa; Stephen D Ryder; Philip Kaye; Guruprasad P Aithal Journal: Int J Hepatol Date: 2012-09-04